School of Medicine
Showing 1-10 of 17 Results
-
Chris Heitzig
Postdoctoral Scholar, Epidemiology
BioChris Heitzig is a New Map of Life Postdoctoral Fellow in the Department of Epidemiology and Population Health. An economist by training, his research develops models to examine healthy aging across the life course, with a particular emphasis on identifying causal pathways and key points of policy intervention to improve well-being in later life. A central focus of his work is the socioeconomic impact of undiagnosed metabolic disorders—how these conditions manifest, the costs of leaving them untreated, and the potential for interventions to improve detection and outcomes. His research combines insights from economics and public health with machine learning methods for causal inference.
Before joining Stanford, Chris served in research roles at the Brookings Institution and the World Bank. At Brookings, he managed a $1.5 million research grant investigating how technological change is reshaping employment in Africa. At the World Bank, he designed randomized controlled trials to measure the causal effects of health and employment programs and served in an operational role as the day-to-day lead for a $20 million job transition program. Chris holds a PhD in Economics from the Institute of Development Studies, an MPhil in Economics from the University of Oxford, and a BA in Economics from Saint John’s University. -
Ixel Hernandez-Castro
Postdoctoral Scholar, Epidemiology
BioEnvironmental epidemiologist focused on understanding how environmental exposures during pregnancy and early life shape maternal and child health across the life course. My work integrates exposure science, epidemiologic methods, and molecular biomarkers to uncover biological pathways linking chemical and non-chemical stressors to pregnancy complications and adverse cardiometabolic and neurological outcomes.
-
Amy M Inkster
Postdoctoral Scholar, Epidemiology
BioAmy Inkster, PhD is a Postdoctoral Scholar in the Department of Epidemiology and Population Health at Stanford University. She conducts research on epigenetic alterations in pregnancy and early life to understand the molecular levers affecting healthy development. She primarily uses large 'omics datasets to study the effect of environmental exposures on pregnancy outcomes and maternal health.
Dr. Inkster received her PhD in Medical Genetics from the University of British Columbia (Vancouver, Canada), where her research focused on evaluating DNA methylation variation in prenatal life, primarily in the context of placental epigenetics, sex differences, prenatal exposures, and X-chromosome inactivation. She holds a BSc in Chemistry. As a cross-disciplinary researcher, her work and research interests lie at the intersection of molecular mechanisms and their impacts on human health and disease at the population level. -
Dayoon Kwon
Postdoctoral Scholar, Epidemiology
BioI am an environmental epidemiologist who integrates omics data to understand how environmental exposures shape human health across the life course. At Stanford, I develop epigenetic biomarkers and aging clocks that capture how environmental exposures affect aging and disease. During my PhD at UCLA, I investigated air pollution and Parkinson’s disease, focusing on gene-environment interactions and metabolomics. Previously at Columbia, I quantified biological aging using blood-based biomarkers.
-
Lili Liu
Postdoctoral Scholar, Epidemiology
BioLili (Larry) Liu, PhD, is a postdoctoral fellow in the Department of Epidemiology and Population Health at Stanford University. Dr. Liu is an integrative epidemiologist whose research is unified by a consistent methodological approach rather than a single disease area. Across his master’s, doctoral, and postdoctoral training, he has repeatedly developed or operationalized epidemiologic frameworks and analytic programs and applied them to important public health questions spanning rare diseases, chronic disease, cancer, mortality, microbiome, and women’s health. His work brings together molecular biomarkers, large-scale population cohorts, and real-world health data to generate coherent, hypothesis-driven research on how genetic variation, lifestyle, pharmacologic factors, and early-life exposures shape inflammation, biological aging, and chronic disease risk across the life course.
During his master’s training at Peking University, Dr. Liu developed expertise in literature synthesis, national claims-based study, rare disease burden estimation, patient-centered health information research, cohort-based analysis, and vaccine effectiveness evaluation. He helped build and apply claims-based analytic algorithms to estimate incidence and prevalence for multiple rare diseases in China, led first-author studies on online health information and patient information needs in rare disease populations, and established an analytic framework for CHARLS-based cohort studies that supported multiple downstream projects. During his PhD training at Vanderbilt University, he expanded into population genetics, molecular and cancer epidemiology, mortality and health disparities research, gut microbiome, and pooled multi-study analyses. His doctoral work included a multi-ancestry GWAS of urinary prostaglandin E2 metabolite (PGE-M), development of PGE-M-derived dietary and lifestyle scores, and Mendelian randomization analyses linking lipid-related pathways to colorectal cancer risk. He also led several first-author studies in the Southern Community Cohort Study on poverty, sitting time, physical activity, walking and mortality, and alcohol intake and the gut microbiome, several of which received substantial public health and media attention.
At Stanford, Dr. Liu has developed an independent research program centered on women’s health and life-course epidemiology using U.S. national claims data. He has built large nationwide pregnancy and mother-baby cohorts from MarketScan to study adverse obstetric outcomes, long-term cardiometabolic and hepatic outcomes, and early-onset cancer risk. His first corresponding-author paper at Stanford examined gestational diabetes in relation to subsequent type 2 diabetes and metabolic dysfunction-associated steatotic liver disease, and his ongoing work extends this framework to cardiovascular, kidney, metabolic, and reproductive health outcomes, including PCOS and endometriosis. He also received a Stanford MCHRI fellowship grant to study prenatal and early-life antibiotic exposure in relation to pediatric inflammatory bowel disease and celiac disease. In parallel, his collaborative work includes placental and maternal-fetal research on extracellular vesicles and angiogenic signaling.
Methodologically, Dr. Liu works at the interface of causal inference, pharmacoepidemiology, molecular epidemiology, and scalable real-world data science, using reproducible analytic pipelines in R, Python, SQL, and high-performance computing environments. Across all stages of his training, the central theme of his work has been to build scalable analytic infrastructure and apply it to high-impact epidemiologic questions with broad public health relevance, with the overarching goal of translating rigorous population science into actionable strategies for chronic disease prevention in diverse populations.